Litcius/Paper detail

Infectious Agents as Potential Drivers of α‐Synucleinopathies

Morgane Linard, Alix Ravier, Louisa Mougué, Iris Grgurina, Anne‐Laurence Boutillier, Alexandra Foubert‐Samier, Frédéric Blanc, Catherine Helmer

2022Movement Disorders15 citationsDOI

Abstract

α-synucleinopathies, encompassing Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, are devastating neurodegenerative diseases for which available therapeutic options are scarce, mostly because of our limited understanding of their pathophysiology. Although these pathologies are attributed to an intracellular accumulation of the α-synuclein protein in the nervous system with subsequent neuronal loss, the trigger(s) of this accumulation is/are not clearly identified. Among the existing hypotheses, interest in the hypothesis advocating the involvement of infectious agents in the onset of these diseases is renewed. In this article, we aimed to review the ongoing relevant factors favoring and opposing this hypothesis, focusing on (1) the potential antimicrobial role of α-synuclein, (2) potential entry points of pathogens in regard to early symptoms of diverse α-synucleinopathies, (3) pre-existing literature reviews assessing potential associations between infectious agents and Parkinson's disease, (4) original studies assessing these associations for dementia with Lewy bodies and multiple system atrophy (identified through a systematic literature review), and finally (5) potential susceptibility factors modulating the effects of infectious agents on the nervous system. © 2022 International Parkinson and Movement Disorder Society.

Topics & Concepts

SynucleinopathiesDementia with Lewy bodiesDementiaNeuroscienceParkinson's diseaseAtrophyDiseaseMedicineAlpha-synucleinBiologyPathologyParkinson's Disease Mechanisms and TreatmentsBotulinum Toxin and Related Neurological DisordersAlzheimer's disease research and treatments